BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 11097797)

  • 21. Risk factors for late-onset Alzheimer's disease: a population-based, case-control study.
    Fratiglioni L; Ahlbom A; Viitanen M; Winblad B
    Ann Neurol; 1993 Mar; 33(3):258-66. PubMed ID: 8498809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
    Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
    Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allele epsilon 4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy.
    Bosco P; Guéant-Rodríguez RM; Anello G; Spada RS; Romano A; Caraci F; Ferri R; Guéant JL
    Neurosci Lett; 2005 Nov; 388(3):168-72. PubMed ID: 16040191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of late-onset Alzheimer's disease associated with BDNF C270T polymorphism.
    Olin D; MacMurray J; Comings DE
    Neurosci Lett; 2005 Jun; 381(3):275-8. PubMed ID: 15896483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alcohol intake and risk of dementia.
    Luchsinger JA; Tang MX; Siddiqui M; Shea S; Mayeux R
    J Am Geriatr Soc; 2004 Apr; 52(4):540-6. PubMed ID: 15066068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome scan on Swedish Alzheimer's disease families.
    Sillén A; Forsell C; Lilius L; Axelman K; Björk BF; Onkamo P; Kere J; Winblad B; Graff C
    Mol Psychiatry; 2006 Feb; 11(2):182-6. PubMed ID: 16288313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the effect of aluminum in drinking water and transferrin C2 allele on Alzheimer's disease.
    Rondeau V; Iron A; Letenneur L; Commenges D; Duchêne F; Arveiler B; Dartigues JF
    Eur J Neurol; 2006 Sep; 13(9):1022-5. PubMed ID: 16930371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between HLA-A alleles and Alzheimer's disease in a southern Chinese community.
    Ma SL; Tang NL; Tam CW; Lui VW; Suen EW; Chiu HF; Lam LC
    Dement Geriatr Cogn Disord; 2008; 26(5):391-7. PubMed ID: 18936542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
    Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
    Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of depression with Alzheimer's disease and vascular dementia in an elderly Arab population of Wadi-Ara, Israel.
    Bowirrat A; Oscar-Berman M; Logroscino G
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):246-51. PubMed ID: 16477584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
    Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
    Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
    Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
    Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease.
    van Exel E; Eikelenboom P; Comijs H; Frölich M; Smit JH; Stek ML; Scheltens P; Eefsting JE; Westendorp RG
    Arch Gen Psychiatry; 2009 Nov; 66(11):1263-70. PubMed ID: 19884614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories.
    McLachlan DR; Bergeron C; Smith JE; Boomer D; Rifat SL
    Neurology; 1996 Feb; 46(2):401-5. PubMed ID: 8614502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aluminum and Alzheimer's disease].
    Belojević G; Jakovljević B
    Srp Arh Celok Lek; 1998; 126(7-8):283-9. PubMed ID: 9863396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Etiology of Alzheimer's disease].
    Wöber C; Dal-Bianco P; Hufgard J; Lind C; Deecke L
    Nervenarzt; 1992 Feb; 63(2):74-81. PubMed ID: 1565172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aluminum fractions in drinking water from reservoirs.
    Schintu M; Meloni P; Contu A
    Ecotoxicol Environ Saf; 2000 May; 46(1):29-33. PubMed ID: 10805990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of clinically diagnosed Alzheimer's disease.
    Rocca WA; Amaducci LA; Schoenberg BS
    Ann Neurol; 1986 May; 19(5):415-24. PubMed ID: 3717905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.